Literature DB >> 1554212

Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects.

V Hoffstein1, S Viner, S Mateika, J Conway.   

Abstract

Obstructive sleep apnea is a chronic disease whose treatment may require long-term nightly use of relatively cumbersome and expensive breathing equipment that provides continuous positive airway pressure (CPAP) via nasal mask. Compliance with this treatment may be influenced not only by the objective improvement in sleep apnea but also by the patient's subjective perception of the benefit, bed mate or family support, side effects, and cost. The last factor may not be important in Ontario, where 75% of the cost is paid by the Ministry of Health. The goal of this study was to analyze the factors that may influence patient acceptance of nasal CPAP. This was done by tabulating the responses to a detailed questionnaire mailed to 148 patients with obstructive sleep apnea (OSA). There were 96 replies. We were able to contact by telephone an additional 42 patients. The results showed that 105 patients continued to use CPAP at a mean follow-up time of 17 +/- 11 months, some for as long as 6 yr. The majority of patients (81%) perceived CPAP as an effective treatment of the disorder, 5% were unsure, and 14% believed that CPAP was ineffective, despite the resolution of sleep apnea on polysomnography. Subjective improvement reported by the patients was also observed by the family members in 83% of the patients. The most common complaint, voiced by 46% of the patients, was nocturnal awakenings. Nasal problems, such as dryness, congestion, and sneezing, were the second most frequent complaint present in 44% of the responders.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1554212     DOI: 10.1164/ajrccm/145.4_Pt_1.841

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  57 in total

1.  A critical evaluation of surgery for sleep disordered breathing.

Authors:  Boris A Stuck
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2006-10-05

Review 2.  Factors that influence CPAP adherence: an overview.

Authors:  Gilla K Shapiro; Colin M Shapiro
Journal:  Sleep Breath       Date:  2010-07-27       Impact factor: 2.816

Review 3.  New developments in the use of positive airway pressure for obstructive sleep apnea.

Authors:  Lucas M Donovan; Schafer Boeder; Atul Malhotra; Sanjay R Patel
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 4.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 5.  Clinical review: humidifiers during non-invasive ventilation--key topics and practical implications.

Authors:  Antonio M Esquinas Rodriguez; Raffaele Scala; Arie Soroksky; Ahmed BaHammam; Alan de Klerk; Arschang Valipour; Davide Chiumello; Claude Martin; Anne E Holland
Journal:  Crit Care       Date:  2012-02-08       Impact factor: 9.097

6.  Effects of nasal mask leak and heated humidification on nasal mucosa in the therapy with nasal continuous positive airway pressure (nCPAP).

Authors:  Yvonne Fischer; Tilman Keck; Richard Leiacker; Ajnacska Rozsasi; Gerhard Rettinger; Philipp M Gruen
Journal:  Sleep Breath       Date:  2008-03-01       Impact factor: 2.816

Review 7.  Temperature controlled radiofrequency ablation at different sites for treatment of obstructive sleep apnea syndrome: a systematic review and meta-analysis.

Authors:  Ridhwan Y Baba; Arjun Mohan; V V S Ramesh Metta; M Jeffery Mador
Journal:  Sleep Breath       Date:  2015-02-03       Impact factor: 2.816

8.  Predictors of CPAP compliance in different clinical settings: primary care versus sleep unit.

Authors:  Núria Nadal; Jordi de Batlle; Ferran Barbé; Josep Ramon Marsal; Alicia Sánchez-de-la-Torre; Nuria Tarraubella; Merce Lavega; Manuel Sánchez-de-la-Torre
Journal:  Sleep Breath       Date:  2017-09-01       Impact factor: 2.816

9.  All APAPs Are Not Equivalent for the Treatment of Sleep Disordered Breathing: A Bench Evaluation of Eleven Commercially Available Devices.

Authors:  Kaixian Zhu; Gabriel Roisman; Sami Aouf; Pierre Escourrou
Journal:  J Clin Sleep Med       Date:  2015-07-15       Impact factor: 4.062

10.  Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA).

Authors:  Jan H Hollandt; Malte Mahlerwein
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.